Search, analyze & compare

My selected companies

Adjust valuation method
WatchlistNameTickerP/EP/SP/BEV/EbitdaROEROICRSISMA200DCFVolumeClosing price
-
Cytek Biosciences, Inc.CTKB-73.243.701.90-38.13-2.54%-3.18%60.20$6.55-$71.5926,341$5.68

Detail of Cytek Biosciences, Inc.

 
CEO
Dr. Wenbin Jiang Ph.D.
Employees
645
Industry
Medical Devices
Sector
Healthcare
Market cap
$744M

Company details

Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells; and aurora cell sorter system that leverages full spectrum profiling technology to further broaden potential applications across cell analysis; aurora CS systems; amnis imagestream imaging flow cytometers; guava muse cell analyzers; guava easycyte flow cytometers; and orion reagent cocktail preparation systems. The company also provides reagents and kits, including cFluor reagents that are fluorochrome conjugated antibodies used to identify cells of interest for analysis on its instruments, as well as 25-color immunoprofiling assay that provides turnkey solutions for identifying major human immune subpopulations for TBNK cells, monocytes, dendritic cells, and basophils. In addition, it offers automated micro-sampling system and automated sample loader system, an automated loaders to integrate seamlessly into the aurora and northern lights systems; SpectroFlo software that provides intuitive workflow from quality control to data analysis for aurora and northern lights systems; and customer support tools. The company serves pharmaceutical and biopharma companies, academic research centers, and clinical research organizations. It distributes its products through direct sales force and support organizations in North America, Europe, China, and the Asia-Pacific regions; and through distributors or sales agents in European, Latin American, and the Middle Eastern countries. The company was formerly known as Cytoville, Inc. and changed its name to Cytek Biosciences, Inc. in August 2015. Cytek Biosciences, Inc. was founded in 1992 and is headquartered in Fremont, California.

Revenue
Cost of goods
Gross profit
OE
R&D
G&A
OI
OIE
PI
TAX
NI
Revenue (Rev)
$201.21M
Cost of goods (CoG)
-$90.71M
Gross profit (GP)
$110.50M
Operating expense (OE)
-$134.15M
Research and development (R&D)
-$40.55M
General and administrative (G&A)
-$93.60M
Operating income (OI)
-$23.65M
Other income expense (OIE)
-$7.17M
Pretax income (PI)
-$11.91M
Tax (TAX)
$1.75M
Net income (NI)
-$10.16M
Cytek Biosciences, Inc.
CTKB • XNGS • US
$5.68
-2.94 (-34.11%)
Stock vs Industry average
  • Industry average

Negative values are hidden from the graph.
Trailing annual dividend rate
$0.00
Payout ratio
0.00%
EPS
-$0.08
Margin profit
-5.05%
52 week low
$4.69
52 week high
$9.15
50-day simple moving average
$6.73
200-day simple moving average
$6.55
Percent held by insiders
8.85%
Percent held by institutions
59.02%
Dividend yield
0.00%

Change of shares

Cash vs Debt

Insider Trading

Comparison of selected companies

 
%
Price change
CTKB -34.11%
eps change
CTKB 0.00%